LONDON, UK I3, 2024 I Vicebio Ltd ("Vicebio"), a biopharmaceutical company developing novel vaccines against life-threatening respiratory viral ...

NEW HAVEN, CT, USA I3, 2024 I Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), today announced positive topline results from ...

SYDNEY, Australia I September 23, 2024 I Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is pleased to announce the ...

In preclinical studies ARO-INHBE reduced body weight and fat mass with a novel mechanism of action that may preserve lean muscle mass compared to currently ...

Funding co-led by the Bill & Melinda Gates Foundation and Amplitude Ventures to advance a new class of multi-functional biologics ...

PARIS, France and TARRYTOWN, NY, USA I 11, 2024 I A Dupixent (dupilumab) confirmatory phase 3 study (LIBERTY-CUPID Study C) met the primary and key ...

BERLIN, Gwrmany I September 09, 2024 I Bayer announced encouraging results from the expansion part of the ongoing Phase I/II SOHO-01 study evaluating the safety and preliminary efficacy of BAY 2927088 ...

PARIS, France, and HOUSTON, TX, USA I 12, 2024 I As part of its effort to develop innovative treatments for people living with rare cancers, Sanofi ...

COLUMBUS, OH, USA I September 10, 2024 I Basking Biosciences (Basking), a clinical-stage biopharmaceutical company developing a novel acute thrombolytic therapy, today announced that the first ...

LONDON, UK I 09, 2024 I GSK plc (LSE/NYSE: GSK) today presented the full results from the SWIFT-1 and SWIFT-2 phase III clinical trials which ...

SAN DIEGO, CA, USA I 9, 2024 I Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and ...

MUNICH & GARCHING, Germany & LAUSANNE, Switzerland I 12, 2024 I ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical ...